United States Therapeutic Plasma Exchange Market to grow at high CAGR | Top Companies - Asahi Kasei Corporation., Baxter International Inc., Terumo Corporation. | Exclusive report by DataM intelligence

Leander, Texas and Tokyo, Japan - Jan.16.2026
As per DataM intelligence research report "Therapeutic Plasma Exchange Market is anticipated to grow at a high CAGR during the forecast period 2024-2031."

The therapeutic plasma exchange market is growing as advanced equipment and procedural innovations improve patient outcomes. Automation, high-efficiency plasma separators, and safety enhancements increase clinical effectiveness. Rising prevalence of autoimmune and hematologic disorders is fueling global adoption.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/therapeutic-plasma-exchange-market?prasad

Therapeutic Plasma Exchange Market: Competitive Intelligence
Asahi Kasei Corporation., Baxter International Inc., Terumo Corporation., B. Braun Melsungen AG., Fresenius Kabi AG., Haemonetics Corporation

In the Therapeutic Plasma Exchange Market, Asahi Kasei Corporation, Baxter International Inc., Terumo Corporation, B. Braun Melsungen AG, Fresenius Kabi AG, and Haemonetics Corporation collectively strengthen a critical segment of apheresis and extracorporeal therapies that support treatment of autoimmune disorders, hematologic conditions, and metabolic imbalances. These companies provide advanced devices, single-use kits, and integrated system components that help clinicians perform plasma exchange procedures with precision, safety, and efficiency. Their solutions support improved patient outcomes by enabling rapid removal of pathological plasma constituents while preserving vital blood components, which is essential in indications such as thrombotic microangiopathies, neurological autoimmune diseases, and certain renal conditions. With broad geographic distribution and service networks, they help ensure reliable access to therapeutic plasma exchange technologies across hospitals, specialty centers, and transfusion services. Together, they reinforce the Therapeutic Plasma Exchange Market by enhancing procedural quality, clinical confidence, and operational continuity in diverse care settings.

Individually and collectively, these firms' strengths create competitive advantage and innovation momentum within the Therapeutic Plasma Exchange Market by blending engineering excellence, regulatory compliance, and comprehensive support infrastructures. Asahi Kasei Corporation contributes specialized filtration and membrane technologies that improve separation efficiency and biocompatibility. Baxter International Inc. and Fresenius Kabi AG bring robust portfolios of apheresis systems and consumables backed by extensive clinical experience and global service networks, supporting adoption in high-volume centers. Terumo Corporation and B. Braun Melsungen AG enhance this landscape with precision engineering, ergonomic system designs, and integrated safety features that help clinicians optimize workflows and patient comfort. Haemonetics Corporation adds value with innovative automation and connectivity capabilities that support data-driven procedure management and enhanced traceability. Together, these companies advance the Therapeutic Plasma Exchange Market by delivering complementary solutions that help healthcare providers meet complex clinical needs while managing cost, quality, and scalability.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/therapeutic-plasma-exchange-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Terumo BCT introduced automated plasma exchange systems with robotics, AI-enabled flow monitoring, and real-time analytics to improve safety, efficiency, and patient-specific plasma management.

✅ In November 2025, Baxter International invested $40 million to upgrade automated therapeutic plasma exchange systems integrating AI-controlled flow management and robotic blood handling for clinical use.

✅ In August 2025, Haemonetics deployed robotic-assisted plasma exchange systems with AI-driven monitoring to optimize replacement therapy and enhance operational efficiency.

✅ In June 2025, Fresenius Kabi implemented automated TPE platforms with AI flow analytics, robotics, and integrated monitoring to improve patient safety and standardize procedures.

Japan: Recent Industry Developments

✅ In January 2026, Terumo Corporation deployed automated AI-assisted plasma exchange platforms, supported by $25 million investment, integrating robotics and real-time monitoring to improve procedure efficiency and patient safety.

✅ In October 2025, Nipro Corporation introduced robotics-assisted therapeutic plasma exchange systems with AI-enabled flow analytics to standardize clinical operations.

✅ In July 2025, Asahi Kasei Medical launched automated plasma exchange platforms with AI-driven monitoring and robotic handling to enhance consistency and safety in procedures.

✅ In April 2025, Kaneka Medical deployed automated TPE systems integrating robotics and AI analytics to optimize plasma separation and replacement therapy outcomes.

Segment Covered in the Therapeutic Plasma Exchange Market:
By Product Type
The market is segmented into apheresis machines (50%), filters (35%), and others (15%), with apheresis machines dominating due to their central role in therapeutic plasma exchange procedures and widespread hospital adoption. Filters are growing with increasing procedure volumes, while other accessories support specialized clinical needs.

By Indication
Indications include neurological disorders (30%), cardiovascular disorders (20%), hematology disorders (25%), renal disorders (15%), and others (10%). Neurological disorders dominate due to high prevalence of conditions such as Guillain-Barre Syndrome and Multiple Sclerosis treated via plasma exchange. Hematology and cardiovascular applications show steady growth with rising awareness and clinical adoption.

By End-User
End-users include hospitals (65%), ambulatory surgical centers (20%), and others (15%). Hospitals lead due to advanced infrastructure and trained personnel. Ambulatory centers are expanding for outpatient plasma exchange treatments, while other specialized facilities cater to rare or emergency indications.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=therapeutic-plasma-exchange-market

Regional Analysis
North America - 40% Share
North America leads the market due to high adoption of advanced apheresis technologies, well-established healthcare infrastructure, and rising prevalence of neurological and hematological disorders in the U.S. and Canada.

Europe - 30% Share
Europe holds a significant share, driven by strong hospital networks, insurance reimbursement for plasma exchange procedures, and increasing patient awareness in Germany, France, and the U.K.

Asia Pacific - 20% Share
Asia Pacific is a growing market, with increasing healthcare infrastructure, rising incidence of autoimmune and hematology disorders, and expanding adoption in China, Japan, and India.

Latin America - 7% Share
Latin America is emerging, supported by government healthcare programs and increasing adoption in Brazil and Mexico.

Middle East & Africa - 3% Share
The Middle East & Africa region is nascent, driven by growing awareness, investment in healthcare infrastructure, and demand for advanced therapeutic procedures.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.